Search Results - "Holyoake, Daniel L.P."

Systematic review and meta-analysis of small bowel dose–volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy by Holyoake, Daniel L.P, Partridge, Mike, Hawkins, Maria A

“…Highlights•Acute GI toxicity is highly prevalent and dose-limiting in the treatment of rectal cancer. •The dose–volume relationship for the small bowel is…”
Get full text

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data by Holyoake, Daniel L.P, Aznar, Marianne, Mukherjee, Somnath, Partridge, Mike, Hawkins, Maria A

“…Abstract Background and purpose Gastro-intestinal toxicity is dose-limiting in abdominal radiotherapy and correlated with duodenum dose-volume parameters. We…”
Get full text

Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer by Holyoake, Daniel L.P, Robinson, Maxwell, Grose, Derek, McIntosh, David, Sebag-Montefiore, David, Radhakrishna, Ganesh, Patel, Neel, Partridge, Mike, Mukherjee, Somnath, Hawkins, Maria A

“…Abstract Background and purpose Margin-directed neoadjuvant radiotherapy for borderline-resectable pancreatic cancer (BRPC) aims to facilitate clear surgical…”
Get full text

Chemoradiotherapy or Surgery for Very Early Esophageal Squamous Cancer: Can a Nonrandomized Trial Give Us the Answer? by Holyoake, Daniel L.P., Smyth, Elizabeth C.

Get full text

SPARC, a phase-I trial of pre‐operative, margin intensified, stereotactic body radiation therapy for pancreatic cancer by Holyoake, Daniel L.P., Robinson, Maxwell, Silva, Michael, Grose, Derek, McIntosh, David, Sebag-Montefiore, David, Radhakrishna, Ganesh, Mukherjee, Somnath, Hawkins, Maria A.

“…•Prospective study of pre-operative margin intensified SBRT in borderline resectable pancreatic cancer.•All SBRT was completed, dose was escalated one level…”
Get full text

Superior outcomes of nodal metastases compared to visceral sites in oligometastatic colorectal cancer treated with stereotactic ablative radiotherapy by O'Cathail, Sean M., Smith, Thomas, Owens, Rob, Zeniou, Anthi, Tsang, Yatman, Holyoake, Daniel L.P., Murray, Louise, Harrison, Mark, Hawkins, Maria A.

“…•SBRT for CRC results in excellent local control rates for nodal metastases.•Median PFS for NM was 19 months versus 9 months for VM.•Nodal site was significant…”
Get full text